Hair loss is another side effect that concerns many users
Some patients hold at lower doses for longer periods if they are experiencing adequate appetite suppression and weight loss
Although Semaglutide GLP-1 starts acting soon after injection, most people dont notice significant effects immediately
Malhotra A et al., SURMOUNT-OSA, NEJM 2024 (NEJMoa2404881, PMID 38912654) : tirzepatide and obstructive sleep apnea, AHI -25,3 to 52 weeks
This association has been observed for many years in other clinical studies looking at other methods of tightening blood sugar, but for most people, the risks are manageable by seeing a retina specialist well versed in treating diabetic eye disease
Tirzepatide (Mounjaro and Zepbound), a GLP-1 and GIP receptor agonist, has recently gained significant popularity for its weight loss benefits